Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 5/20 | 0.47 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 8/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPR3 | P17342 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28516209 | 1.00 | NPSR1 (0.47) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL2059013 | 0.86 | TAS1R3 (0.46) | POLB | |
| SCHEMBL7367580 | 0.83 | MAPT (0.48) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL7343698 | 0.83 | NPSR1 (0.48) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL6224857 | 0.83 | MAPT (0.48) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL10210577 | 0.81 | NPSR1 (0.50) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL12627973 | 0.81 | NPSR1 (0.50) | NPSR1TDP1POLBCTSLCTSB | |
| SCHEMBL14856408 | 0.81 | TDP1 (0.37) | NPSR1TDP1POLBCTSKMAPT | |
| SCHEMBL13863595 | 0.81 | TDP1 (0.37) | NPSR1TDP1POLBCTSKMAPT | |
| SCHEMBL21675512 | 0.80 | CTSK (0.61) | NPSR1TDP1POLBCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319341-B2 | Immune-stimulating soluble doxorubicin-conjugated complex | YAFEI (SHANGHAI) BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-05-03 | — | — | US | disclosed |
| US-20200247842-A1 | Immune-stimulating soluble doxorubicin-conjugated complex | YAFEI (SHANGHAI) BIOPHARMACEUTICAL CO LTD (CN) | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200247842-A1 | Immune-stimulating soluble doxorubicin-conjugated complex | TLR3, CD40, TLR6 | NPSR1 2779/4885TDP1 4677/4885POLB 3043/4885 |
| US-11319341-B2 | Immune-stimulating soluble doxorubicin-conjugated complex | TLR3, CD40, TLR6 | NPSR1 2779/4885TDP1 4677/4885POLB 3043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.